4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-14-007822
CIK 0001369786operating
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 9:15 PM ET
Size
5.3 KB
Accession
0001181431-14-007822
Insider Transaction Report
Form 4
Greve Jeffrey W.
Vice President, Controller
Transactions
- Award
Stock Option to Buy
2014-02-18+8,865→ 8,865 totalExercise: $20.16Exp: 2024-02-18→ Common Stock (8,865 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 18, 2015.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 9:15 PM ET
- Size
- 5.3 KB